Gilead Sciences (GILD) Intangibles (2009 - 2026)

Gilead Sciences (GILD) posted Intangibles of $16.4 billion for Q1 2026, down 3.51% quarter-over-quarter from $17.0 billion in Q4 2025, and down 15.36% year-on-year from $19.4 billion in Q1 2025.

Gilead Sciences (GILD) Intangibles (2009 - 2026) Analysis & Trends

Gilead Sciences (GILD) has reported Intangibles for 18 consecutive years, with $16.4 billion the latest figure, recorded in Q1 2026.

  • Intangibles for Q1 2026 came in at $16.4 billion, down 15.36% year-over-year; the trailing twelve-month figure through Mar 2026 was $16.4 billion (down 15.36% YoY), and the FY2025 annual result was $17.0 billion, down 14.89% from the prior year.
  • Intangibles was $16.4 billion for Q1 2026 at Gilead Sciences, down from $17.0 billion in the prior quarter.
  • Over five years, Intangibles peaked at $30.3 billion in Q1 2022 and troughed at $16.4 billion in Q1 2026.
  • Average Intangibles over 5 years is $23.8 billion, with a median of $23.4 billion recorded in 2024.
  • Year-over-year, Intangibles declined 6.54% in 2023 and fell 24.59% in 2024.
  • Over 5 years, Intangibles stood at $28.9 billion in 2022, then dropped by 8.44% to $26.5 billion in 2023, then retreated by 24.59% to $19.9 billion in 2024, then decreased by 14.89% to $17.0 billion in 2025, then decreased by 3.51% to $16.4 billion in 2026.
  • Per Business Quant data, the three most recent Intangibles figures were $16.4 billion in Q1 2026, $17.0 billion in Q4 2025, and $18.0 billion in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Intangibles (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn 7.37 Bn
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn 49.06 Bn
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn 50.87 Bn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn 36.91 Bn
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn 25.75 Bn
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn 21.38 Bn
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn 16.38 Bn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn 52.56 Bn
9 Novartis Ag 113.45 Bn 113.67 Bn - 11.30 Bn
10 Biogen 30.87 Bn 26.59 Bn 1.82 Bn 9.05 Bn

Historic Data

Download Data
DateValue
Mar 31, 2026 16.38 Bn
Dec 31, 2025 16.98 Bn
Sep 30, 2025 17.97 Bn
Jun 30, 2025 18.57 Bn
Mar 31, 2025 19.36 Bn
Dec 31, 2024 19.95 Bn
Sep 30, 2024 20.55 Bn
Jun 30, 2024 22.83 Bn
Mar 31, 2024 23.43 Bn
Dec 31, 2023 26.45 Bn
Sep 30, 2023 27.15 Bn
Jun 30, 2023 27.75 Bn
Mar 31, 2023 28.35 Bn
Dec 31, 2022 28.89 Bn
Sep 30, 2022 29.44 Bn
Jun 30, 2022 29.89 Bn
Mar 31, 2022 30.33 Bn
Dec 31, 2021 33.46 Bn
Sep 30, 2021 33.90 Bn
Jun 30, 2021 34.34 Bn